Biogen Inc. buy Guggenheim
Start price
01.05.23
/
50%
€281.00
Target price
01.05.24
€317.14
Performance (%)
-28.01%
End price
02.05.24
€202.30
Summary
This prediction ended on 02.05.24 with a price of €202.30. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -28.01%. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -0.924% | -0.924% | 22.336% |
| iShares Core DAX® | -0,44 % | -5,31 % | 1,44 % |
| iShares Nasdaq 100 | -0,19 % | 3,08 % | 18,68 % |
| iShares Nikkei 225® | -0,95 % | -5,88 % | 27,86 % |
| iShares S&P 500 | -0,42 % | 0,92 % | 13,17 % |
Comments by Guggenheim for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $350.00 price target on the stock, up previously from $270.00.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten